OSE Immunotherapeutics SA
ORPOF News Today: Stay Updated with the Latest OSE Immunotherapeutics SA News in Real Time
Find ORPOF news now at Meyka AI. Stay informed with the latest OSE Immunotherapeutics SA stocks updates, including price news, market analysis, and expert insights.
OSE.PA stock surges 16% on FDA orphan drug designation for VEL-101
OSE.PA jumps 16.18% to €4.25 on FDA orphan drug designation for partner Veloxis’ VEL-101 heart transplant therapy.
QPTFF Stock Surges on 225K Volume Spike: Quest PharmaTech Analysis
QPTFF stock trades at $0.0304 with 225,625 volume spike. Quest PharmaTech cancer immunotherapy focus. PNK market analysis.
OSE.PA stock surges 26.5% on FDA orphan drug designation for VEL-101
OSE Immunotherapeutics (OSE.PA) jumps 26.5% to €3.89 on FDA orphan drug designation for heart transplant rejection prevention.
ALVIO.PA stock down 18.94% pre-market 19 Mar 2026: €0.107 test and what to watch next
Pre-market: ALVIO.PA stock falls 18.94% to €0.107 on EURONEXT; quick analysis, Meyka AI grade and forecast
Pre-market most active: ALNEV.PA Neovacs S.A. (EURONEXT) €0.001 17 Mar 2026: high volume
ALNEV.PA stock trades €0.001 pre-market with heavy volume; quick fundamentals, technicals and Meyka AI forecast
SIGHT.PA GenSight Biologics EURONEXT 16 Mar 2026 earnings: catalysts to watch
Intraday earnings preview for SIGHT.PA stock: GenSight Biologics earnings on 20 Mar 2026, catalysts, forecast and Meyka AI grade
SIGHT.PA GenSight Biologics EURONEXT after hours: down 16.15% to €0.09, catalysts ahead
SIGHT.PA stock falls 16.15% after hours to €0.09; our grade, ratios and €0.08 forecast for investors
Pre-Market: NANO.PA Nanobiotix (EURONEXT) €33.50 (+16.93%) 10 Mar 2026: momentum
Pre-market update on NANO.PA stock at €33.50 on heavy volume; technical momentum and Meyka grade explained
ALMDP.PA €0.35 Medesis Pharma EURONEXT pre-market 05/03/2026: Oversold bounce
Pre-market ALMDP.PA stock at €0.35 on 05/03/2026. Oversold bounce setup with a short-term target and risk points.